Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin in clinical practice.

J Jankovic1

  • 1Department of Neurology, Baylor College of Medicine, Houston, Texas 77030,USA. josephj@bcm.tmc.edu

Journal of Neurology, Neurosurgery, and Psychiatry
|June 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biliary Enterocytozoon bieneusi infection in a dog under immunomodulatory therapy.

The Journal of small animal practice·2023
Same author

Hyperkinetic movement disorders in congenital disorders of glycosylation.

European journal of neurology·2019
Same author

McLeod syndrome: Five new pedigrees with novel mutations.

Parkinsonism & related disorders·2019
Same author

Association between non-communicable disease multimorbidity and health care utilization in a middle-income country: population-based study.

Public health·2018
Same author

Treatment options for chorea.

Expert review of neurotherapeutics·2017
Same author

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Movement disorders : official journal of the Movement Disorder Society·2017
Same journal

Cancer risk and mortality in patients with multiple sclerosis in Finland: a retrospective population-based cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Visuospatial working memory in Huntington's disease: behavioural and structural brain correlates.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Characteristics and outcomes in electric scooter-related traumatic brain injuries in Helsinki.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Durable fluoropolymer drug-eluting stent versus bare-metal stent for the prevention of intracranial in-stent restenosis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same journal

Correction: <i>How well do plasma Alzheimer's disease biomarkers reflect the CSF amyloid status?</i>

Journal of neurology, neurosurgery, and psychiatry·2026
See all related articles

Botulinum toxin is a potent therapeutic agent that can safely and effectively treat disorders of muscle contraction and autonomic dysfunction. Evidence supports its use in both approved and off-label indications when administered correctly.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Botulinum toxin is a potent neurotoxin with established therapeutic applications.
  • Its mechanism of action and clinical utility continue to be areas of active research.
  • The toxin is utilized for conditions involving muscle overactivity and autonomic nervous system dysfunction.

Purpose of the Study:

  • To review recent findings on the mechanism of action of botulinum toxin.
  • To summarize evidence-based data on its frequent clinical applications.
  • To highlight its safety and efficacy in both approved and off-label uses.

Main Methods:

  • Review of double-blind, placebo-controlled studies.
  • Analysis of open-label clinical trials.

Related Experiment Videos

  • Assessment of long-term safety and efficacy data.

    • Main Results:

    • Botulinum toxin effectively ameliorates disorders of excessive muscle contraction and autonomic dysfunction.
    • Appropriate target selection and dosage are crucial for therapeutic success.
    • The risk of blocking antibodies is minimal with injections every three months or less.
    • Long-term use demonstrates consistent safety and efficacy.

    Conclusions:

    • Botulinum toxin is a safe and effective therapeutic agent for a wide range of clinical applications.
    • Its use extends to numerous off-label indications beyond approved treatments.
    • Evidence supports its role in managing conditions related to neuromuscular and autonomic disorders.